December 19th 2024
Scinai Bioservices Inc. has been established in Delaware as the company's new US-based subsidiary, which will serve biotech companies in early stage drug development.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
CPHI Milan 2024: Evolution of Coating Design
October 9th 2024Pharmaceutical Technology Europe spoke with Ali Rajabi-Siahboomi, vice president and chief innovation officer at Colorcon, about the evolution of coating design and how it has impacted investment, as well as innovations in packaging for oral solid dosage products.